The results of these studies will give us tremendous insight into how GLP-1s work in the brain and potentially broaden and distinguish the therapeutic benefits of this class from the weight loss/appetite suppression mechanism, opening the addressable patient population for this class of medicines beyond comorbid T2D and Obesity conditions
Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials FDA warns about unapproved GLP-1 drugs online, calls for accessible trials The FDA has issued warnings about unapproved GLP-1 drugs circulating online - counterfeit, compounded, or mislabeled as research use only. When access to legitimate GLP-1 clinical trials is limited - by geography, logistics, or site capacity - progress slows
Remember, wellness is a journey of small, consistent choices
However, if you anticipate discomfort and remind yourself why you started, you're already ahead
A number of medication options can help you manage leg pain associated with UC
GIP (glucose-dependent insulinotropic polypeptide) is another gut hormone that works synergistically with GLP-1